Bionter Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Liquidation
Bionter General Information
Description
Developer of analytical testing devices designed for the benefit of people's health. The company's particle testing services are considered potentially critical for patient safety and sub-visible particle testing is mandatory for any parenteral preparation and is being used for stability testing, drug formulation, process development, and IPC testing during manufacturing, enabling clients to have new combination light obscuration technology and smart automation.
Contact Information
Website
www.bionter.comCorporate Office
- Inzlingerstrasse 238
- 4125 Riehen
- Switzerland
Corporate Office
- Inzlingerstrasse 238
- 4125 Riehen
- Switzerland
Bionter Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Bankruptcy: Liquidation | Completed | Out of Business | ||||
| 6. Seed Round | Completed | Generating Revenue | ||||
| 5. Accelerator/Incubator | 28-Sep-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | 27-Apr-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 2. Grant | 18-May-2021 | $11K | $327K | Completed | Generating Revenue | |
| 1. Angel (individual) | 19-Mar-2021 | $327K | $327K | Completed | Startup |
Bionter Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred shares | ||||||||
| Preferred shares | ||||||||
| Preferred shares | 659,586 | $0.010641 | $0.49 | $0.49 | 1x | $0.49 | 2.65% | |
| Ordinary | 9,230,577 | $0.010641 | $0.03 | $0.03 | 1x | $0.03 | 37.1% |
Bionter Patents
Bionter Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4514536-A1 | Single-use, disposable container | Pending | 26-Apr-2022 | ||
| US-12203954-B2 | Single-use, disposable container | Active | 26-Apr-2022 | ||
| US-20230341434-A1 | Single-use, disposable container | Active | 26-Apr-2022 | ||
| US-20250110145-A1 | Single-use, disposable container | Pending | 26-Apr-2022 | ||
| US-D1030471-S1 | Single-use, disposable container | Active | 26-Apr-2022 |
Bionter Signals
Bionter FAQs
-
When was Bionter founded?
Bionter was founded in 2020.
-
Where is Bionter headquartered?
Bionter is headquartered in Riehen, Switzerland.
-
What is the size of Bionter?
Bionter has 7 total employees.
-
What industry is Bionter in?
Bionter’s primary industry is Biotechnology.
-
Is Bionter a private or public company?
Bionter is a Private company.
-
What is Bionter’s current revenue?
The current revenue for Bionter is .
-
How much funding has Bionter raised over time?
Bionter has raised $3.84M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process